1. Home
  2. TWO vs NEO Comparison

TWO vs NEO Comparison

Compare TWO & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Two Harbors Investment Corp

TWO

Two Harbors Investment Corp

HOLD

Current Price

$12.52

Market Cap

1.3B

Sector

Real Estate

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$9.24

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWO
NEO
Founded
2009
2001
Country
United States
United States
Employees
486
N/A
Industry
Real Estate Investment Trusts
Precision Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.0B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
TWO
NEO
Price
$12.52
$9.24
Analyst Decision
Hold
Strong Buy
Analyst Count
7
8
Target Price
$12.56
$13.38
AVG Volume (30 Days)
2.4M
2.0M
Earning Date
04-28-2026
04-28-2026
Dividend Yield
11.77%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.63
Revenue Next Year
N/A
$9.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.84
$4.72
52 Week High
$14.17
$13.74

Technical Indicators

Market Signals
Indicator
TWO
NEO
Relative Strength Index (RSI) 66.49 60.46
Support Level $9.75 $7.42
Resistance Level $12.70 $10.82
Average True Range (ATR) 0.13 0.40
MACD -0.03 0.04
Stochastic Oscillator 56.90 89.45

Price Performance

Historical Comparison
TWO
NEO

About TWO Two Harbors Investment Corp

Two Harbors Investment Corp is a real estate investment trust focused on investing in, financing, and managing residential mortgage-backed securities, residential mortgage loans, mortgage servicing rights, and commercial real estate. The majority of its investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. The company derives revenues mainly from its MSR and Agency RMBS portfolio, including servicing fee income, float income, and interest income, as well as mortgage loan origination activities established to support the MSR portfolio. Its investment portfolio is subject to market risks, mainly interest rate, basis, and prepayment risk. The majority of income is generated by available-for-sale securities.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: